4 – Alzheimers

Vernon Hills, Ill. — Illinois-based biotechnology developer Applied NeuroSolutions and Indianapolis-based drug maker Eli Lilly and Co. announced Tuesday they’ll continue to collaborate on the development of products for the early diagnosis and treatment of Alzheimer’s disease. Applied NeuroSolutions will receive $750,000 from Lilly and later may get up to $25.5 million upon reaching specific …

See original here:
Lilly recommits to Alzheimer’s efforts (The Indianapolis Star)

Tags: 25-5-million, drug-maker, and-later, neuro, vernon-hills, lilly, upon-reaching

Related posts:

1. FDA staff questions Lilly drug for Alzheimer’s test
2. Lilly’s Alzheimer Flop Prods Collaboration
3. Mission man with Alzheimer’s missing since Tuesday afternoon has been found (The Kansas City Star)
4. Lilly, J&J, AstraZeneca Dementia Drugs Boost Deaths in Study
5. Alzheimers Disease: – MetLife Foundation Awards $300,000 to Alzheimer’s Association To Expand Hispanic Outreach Efforts 

This entry was posted on Wednesday, December 23rd, 2009 at 3:57 am and is filed under Alzheimer's Disease. You can follow any responses to this entry through the RSS 2.0 feed. You can leave a response, or trackback from your own site.